CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $763,006 | +65.5% | 16,810 | +104.7% | 0.02% | +110.0% |
Q2 2023 | $461,077 | +59.0% | 8,213 | +28.1% | 0.01% | +25.0% |
Q1 2023 | $290,015 | +7.5% | 6,412 | -3.4% | 0.01% | 0.0% |
Q4 2022 | $269,875 | -48.8% | 6,639 | -17.6% | 0.01% | -50.0% |
Q3 2022 | $527,000 | +2.1% | 8,053 | -5.1% | 0.02% | -27.3% |
Q2 2022 | $516,000 | +11.9% | 8,484 | +15.8% | 0.02% | +46.7% |
Q1 2022 | $461,000 | -13.8% | 7,329 | +3.9% | 0.02% | 0.0% |
Q4 2021 | $535,000 | -51.5% | 7,054 | -28.4% | 0.02% | -57.1% |
Q3 2021 | $1,103,000 | +6.2% | 9,849 | +53.5% | 0.04% | +2.9% |
Q2 2021 | $1,039,000 | +71.7% | 6,416 | +29.4% | 0.03% | +61.9% |
Q1 2021 | $605,000 | -5.9% | 4,960 | +18.1% | 0.02% | -38.2% |
Q4 2020 | $643,000 | +70.1% | 4,199 | -7.0% | 0.03% | +70.0% |
Q3 2020 | $378,000 | +17.0% | 4,516 | +2.9% | 0.02% | -9.1% |
Q2 2020 | $323,000 | +60.7% | 4,387 | -7.1% | 0.02% | +29.4% |
Q1 2020 | $201,000 | -30.0% | 4,723 | +0.4% | 0.02% | -29.2% |
Q4 2019 | $287,000 | -20.7% | 4,704 | -38.7% | 0.02% | -40.0% |
Q2 2019 | $362,000 | – | 7,679 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |